(Q45991888)

English

Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancer.

scientific article published on 28 May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancer. (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

4

object named as

Hitoshi Tsuda

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

Norikazu Masuda

2

object named as

Norikazu Masuda

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

Chikako Shimizu

1

object named as

Chikako Shimizu

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

Yasuhiro Fujiwara

8

object named as

Yasuhiro Fujiwara

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

7

object named as

Kenji Tamura

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

6

object named as

Masashi Ando

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

Kenichi Yoshimura

3

object named as

Kenichi Yoshimura

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

author name string

Masayuki Mano

5

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

publication date

28 May 2009

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

Japanese Journal of Clinical Oncology

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

39

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

8

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

484-490

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP052

21 January 2018

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP052

21 January 2018

Treatment of gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP052

21 January 2018

Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer: accumulating evidence of efficacy, synergy and safety

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP052

21 January 2018

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP052

21 January 2018

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP052

21 January 2018

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP052

21 January 2018

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP052

21 January 2018

Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP052

21 January 2018

Identifiers

10.1093/JJCO/HYP052

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

release_2jhzqq6gvzd65c2bjuc3uj234u

1 reference

https://api.fatcat.wiki/v0/release/2jhzqq6gvzd65c2bjuc3uj234u

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19477897

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45991888&oldid=1856780206"